Publications
669
Citations
64,014
Est. group size
~32
Recurring co-author estimate
Active years
58
Publishing since 1969
Typically publishes in teams of ~6 · 26% small-team papers (≤3 authors) · across 28 venues
- <b>Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial</b>
2026
- <b>Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial</b>
2026
- Per- and polyfluoroalkyl substances and incident metabolic syndrome in midlife women: The Study of Women's Health Across the Nation (SWAN)
Environmental Research · 2026
- Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050
JAMA Network Open · 2025
- Value-Based Pricing of Resmetirom for Metabolic Dysfunction–Associated Steatotic Liver Disease
JAMA Network Open · 2025
- Nonglycemic and glycemic risk factors for painful neuropathic symptoms and for distal symmetrical polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
2025
- Nonglycemic and glycemic risk factors for painful neuropathic symptoms and for distal symmetrical polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
2025
- Cost-effectiveness of diagnosis and treatment of early gestational diabetes mellitus: economic evaluation of the TOBOGM study, an international multicenter randomized controlled trial
EClinicalMedicine · 2024
- Prediabetes and Cardiometabolic Risk: The Need for Improved Diagnostic Strategies and Treatment to Prevent Diabetes and Cardiovascular Disease
Biomedicines · 2024
- Population and Clinical Strategies for the Prevention of Type 2 Diabetes: What's New?
Frontiers research topics · 2024
- Prevalence of distal symmetrical polyneuropathy by Diabetes Prevention Program treatment group, diabetes status, duration of diabetes, and cumulative glycemic exposure
2024
- Prevalence of distal symmetrical polyneuropathy by Diabetes Prevention Program treatment group, diabetes status, duration of diabetes, and cumulative glycemic exposure
2024
- 1875-LB: Adjuvant Glucagon-Like Peptide 1 Receptor Agonist (GLP-1 RA) Use in HNF1A- and HNF4A-MODY
Diabetes · 2024
- Health Insurance Status since the Affordable Care Act among US Adults with and without CKD
Journal of the American Society of Nephrology · 2024
- Prediabetes Diagnosis and Management
JAMA · 2023
- Diabetes Care×74
- Diabetes×15
- ISEE Conference Abstracts×12
- Journal of Diabetes and its Complications×9
- American Journal of Kidney Diseases×8
- W. H. Herman
Medicine · University of Michigan
- Merry Jackson
Medicine · University of Michigan
- Mary Ann Banerji
Medicine · University of Michigan
- Charlton Wilson
Medicine · University of Michigan
- Ranee Chatterjee
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile